53 related articles for article (PubMed ID: 17198582)
1. [Molecular target therapy: a new method in treatment of lung cancer].
Chen LA
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(37):2599-602. PubMed ID: 17198582
[No Abstract] [Full Text] [Related]
2. New approaches in the management of lung cancer.
Kris M
J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S22-4. PubMed ID: 16280107
[No Abstract] [Full Text] [Related]
3. Can epidermal growth factor receptor-fluorescent in situ hybridization predict clinical benefit from cetuximab treatment in patients with non-small-cell lung cancer?
Takano T; Ota S; Hori A; Seki N; Eguchi K
J Clin Oncol; 2009 Jan; 27(3):464-5; author reply 465-7. PubMed ID: 19064956
[No Abstract] [Full Text] [Related]
4. Cetuximab: potential role as first-line treatment for advanced non-small cell lung cancer.
Pirker R
Clin Adv Hematol Oncol; 2008 Oct; 6(10):735-6. PubMed ID: 18997663
[No Abstract] [Full Text] [Related]
5. First-line treatment for advanced nonsmall cell lung cancer harboring activating epidermal growth factor receptor mutation: epidermal growth factor receptor tyrosine kinase inhibitors or chemotherapy?
Gridelli C
Curr Opin Oncol; 2011 Mar; 23(2):131-2. PubMed ID: 21307676
[No Abstract] [Full Text] [Related]
6. Directed therapies in lung cancer: new hope?
Parente Lamelas I; Abal Arca J; Fírvida Pérez JL
Arch Bronconeumol; 2012 Oct; 48(10):367-71. PubMed ID: 22551924
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.
Araújo A; Ribeiro R; Azevedo I; Coelho A; Soares M; Sousa B; Pinto D; Lopes C; Medeiros R; Scagliotti GV
Oncologist; 2007 Feb; 12(2):201-10. PubMed ID: 17296816
[TBL] [Abstract][Full Text] [Related]
8. Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer.
Kotsakis A; Georgoulias V
Expert Opin Pharmacother; 2010 Oct; 11(14):2363-89. PubMed ID: 20586711
[TBL] [Abstract][Full Text] [Related]
9. Cetuximab in non-small-cell lung cancer.
Carillio G; Montanino A; Costanzo R; Sandomenico C; Piccirillo MC; Di Maio M; Daniele G; Giordano P; Bryce J; Normanno N; Rocco G; Perrone F; Morabito A
Expert Rev Anticancer Ther; 2012 Feb; 12(2):163-75. PubMed ID: 22316364
[TBL] [Abstract][Full Text] [Related]
10. Exploring the future of non-small cell lung cancer treatment.
Ramalingam S
Manag Care; 2005 Feb; 14(2 Suppl):9-13; discussion 13-4. PubMed ID: 15776956
[No Abstract] [Full Text] [Related]
11. Developing targeted therapies for lung cancer.
Gandara DR
Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
[No Abstract] [Full Text] [Related]
12. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine.
García B; Neninger E; de la Torre A; Leonard I; Martínez R; Viada C; González G; Mazorra Z; Lage A; Crombet T
Clin Cancer Res; 2008 Feb; 14(3):840-6. PubMed ID: 18245547
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor as a target in cancer therapy.
Kim ES
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S87-95. PubMed ID: 19795581
[TBL] [Abstract][Full Text] [Related]
14. Strategies for overcoming acquired resistance to epidermal growth factor receptor: targeted therapies in lung cancer.
Oxnard GR
Arch Pathol Lab Med; 2012 Oct; 136(10):1205-9. PubMed ID: 23020725
[TBL] [Abstract][Full Text] [Related]
15. Will FLEX allow us flexibility in the therapy of advanced non-small-cell lung cancer? Insights from the 2008 American Society of Clinical Oncology Meeting.
Langer CJ
Clin Lung Cancer; 2008 Sep; 9(5):249-51. PubMed ID: 18824445
[No Abstract] [Full Text] [Related]
16. Perspectives in Lung Cancer--Third Asian-pacific Conference. 11-12 September 2009, Bangkok, Thailand.
Lopes Gde L
IDrugs; 2009 Nov; 12(11):689-91. PubMed ID: 19844853
[TBL] [Abstract][Full Text] [Related]
17. Cetuximab in advanced non-small cell lung cancer.
Rossi A; Maione P; Gridelli C
Crit Rev Oncol Hematol; 2006 Aug; 59(2):139-49. PubMed ID: 16806963
[TBL] [Abstract][Full Text] [Related]
18. [Targeted treatment of advanced lung cancer].
Gauler TC
Dtsch Med Wochenschr; 2013 Oct; 138(40):2034-6. PubMed ID: 24065411
[No Abstract] [Full Text] [Related]
19. Classification of 27 Tumor-Associated Antigens by Histochemical Analysis of 36 Freshly Resected Lung Cancer Tissues.
Kurosawa G; Sugiura M; Hattori Y; Tsuda H; Kurosawa Y
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834817
[TBL] [Abstract][Full Text] [Related]
20. Who will benefit from treatment against EGFR?
Arribas J; Baselga J
Lancet Oncol; 2005 May; 6(5):257-8. PubMed ID: 15863372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
